First Generic Flovent HFA Is Here. What It Could Mean for Asthma Patients and Families
FDA approved the first generic Flovent HFA, but access may still depend on strength, pharmacy supply, insurance coverage, and safe switching.
Healthcare Policy & Access
Federal and state healthcare policy changes affecting access, benefits, eligibility, and care delivery.
-
-
ADHD Medications and Telehealth in 2026: What the Federal Extension Means for Patients
Federal telehealth prescribing flexibility for ADHD stimulants continues through December 31, 2026. Here’s what changed, what did not, and where barriers remain.
-
What SAMHSA’s 2026 988 funding could change first in local communities
SAMHSA’s 2026 988 funding may show up first as faster answers, more local routing, and stronger follow-up, not instant growth in in-person crisis care.
-
What the CY 2026 Medicare physician fee schedule could mean for patient access, preventive care, and physician practices
Medicare’s 2026 physician payment rule may improve care coordination, telehealth, and home visits, but local staffing and practice finances still matter.
-
What the New CMS Prior-Authorization Reports Can and Cannot Tell Patients in 2026
Some plans now have to post 2025 prior-authorization data. Here is what patients and clinicians can learn from the new CMS reports, and what they cannot.
-
Minnesota’s Medicaid funding deferral: Why providers may feel the strain before patients do
Minnesota’s Medicaid funding deferral does not automatically end coverage. The closer short-term risk is provider payment strain, tighter oversight, and access friction.
-
FDA Is Tightening the Rules on Compounded GLP-1 Drugs. What That Could Mean for Access, Safety, and Cost
FDA’s 2026 crackdown on mass-marketed compounded GLP-1s could tighten safety oversight but also shrink cheaper options for people struggling to afford approved drugs.
-
Drug Safety & Recalls | Drug Safety, Shortages & Recalls | Healthcare Policy & Access | Prescriptions
FDA’s compounded GLP-1 crackdown: What changed after Ozempic, Wegovy, Mounjaro, and Zepbound shortages ended
With semaglutide and tirzepatide shortages resolved, the FDA is tightening scrutiny of mass-marketed compounded GLP-1s. Here is what changed and what patients should ask now.
-
Artificial Intelligence | Artificial Intelligence in Healthcare | Healthcare Policy & Access | Medicare & CMS Updates
Original Medicare’s New AI Prior-Authorization Pilot: What Patients in 6 States Should Know
CMS has started a limited Original Medicare pilot in six states that uses technology vendors and clinician review for a narrow set of services. Here’s what WISeR does, what has not changed, how reviews and appeals work, and why some experts worry about delays.
-
ACA Marketplace Coverage Got More Expensive in 2026. What to Do if Premiums Are Higher or You Missed Open Enrollment
ACA Marketplace sign-ups for 2026 came in below last year, and many households are paying more after tax credits. Here is what changed, who may still qualify to enroll, and what to do if your plan or subsidy looks wrong.
-
Health Plans Must Start Posting Prior Authorization Stats by March 31, 2026: What Patients Should Look For
Certain Medicare Advantage, Medicaid, CHIP, and HealthCare.gov marketplace plans now have to post prior authorization data from 2025. Here’s what patients can check, what the numbers mean, and what the reports still leave out.
-
ACA Marketplace in 2026: Why Updating Your Income Matters More Than Ever
If you get Marketplace premium help in 2026, the financial stakes are higher than they were before. Extra pandemic-era subsidy boosts have ended, and for tax years after 2025 there is no repayment cap if you get too much advance premium tax credit. Here’s what that means, who should act now, and where to get help.
-
ACA Marketplace Premiums Are Higher in 2026: What to Know Before You Lose Coverage or Owe Back Tax Credits
Many ACA Marketplace enrollees are paying more in 2026 after enhanced subsidies ended. If you already signed up, now is the time to verify premium payments, update your income information, and understand the risk of retroactive coverage loss or a tax-time payback.
-
Medicare Telehealth in 2026: What Extended Flexibilities Mean for Patients at Home
Medicare has extended many telehealth flexibilities through 2026. Here’s what that means for receiving care at home, what’s covered, what you pay, and what could change next.
-
Healthcare Policy & Access | Hospitals & Healthcare Systems | Medicare & CMS Updates | Rural Health & Access
What MedPAC’s 2026 Report Means for Rural Hospitals — and for Patients Who Rely on Them
A new March 2026 report from MedPAC examines how Medicare payment policy is affecting rural hospital finances and the rise of Rural Emergency Hospitals. Here’s what it means for emergency access, maternity care, travel distances, and insurance coverage in rural communities.
-
Health Costs & Coverage | Healthcare Policy & Access | Psychiatry | Public Health Data & Surveillance
New Federal Data Show Where Mental Health Needs and Treatment Gaps Stand in 2026
The latest federal survey finds mental illness remains common in the U.S., especially among teens and young adults. Millions report serious symptoms each year, and many still do not receive treatment. Here’s what the newest data show—and what it means for families, insurance coverage, and when to seek help.
-
Will Medicare Cover Weight-Loss Drugs in 2026? What New Obesity Medications Mean for Access, Costs, and Care
New FDA-approved obesity medications have changed treatment options—but Medicare’s long-standing drug coverage rules still shape who can access them. Here’s what adults and families should understand in 2026 about eligibility, costs, and policy limits.
-
Health Costs & Coverage | Healthcare Policy & Access | Healthcare Workforce & Staffing | Medicare & CMS Updates
What Medicare’s 2026 Physician Payment Updates Mean for Patients
CMS has finalized the 2026 Medicare Physician Fee Schedule, updating how doctors are paid, refining telehealth rules, and adjusting quality programs. Here’s what those changes could mean for appointment access, costs, and care coordination.
-
Health Costs & Coverage | Health Equity & Disparities | Healthcare Policy & Access | Medicaid & CHIP
What the March 2026 MACPAC Report Means for Medicaid and CHIP Families
The March 2026 MACPAC Report to Congress reviews Medicaid and CHIP enrollment after the COVID-19 unwinding, access to care challenges, managed care oversight, and federal–state financing pressures. Here’s what families should know.
-
Health Costs & Coverage | Healthcare Policy & Access | Hospitals & Healthcare Systems | Medicare & CMS Updates
What CMS’s 2026 Hospital Outpatient Payment Rule Means for Patients and Health Systems
CMS has finalized its 2026 payment rule for hospital outpatient departments and ambulatory surgery centers. Here’s what the changes mean for Medicare patients, hospital finances, and where you receive care.
-
Why Primary Care and Mental Health Shortages Persist in 2026 — and What It Means for Patients
Federal data show that primary care and mental health shortages remain widespread in 2026, especially in rural, tribal, and low-income communities. Here’s what a federal shortage designation means, how it affects wait times and emergency department use, and what’s being done to address the gaps.
-
New Federal Rules Aim to Speed Up Prior Authorization: What Patients Should Know in 2026
New federal rules are rolling out in 2026–2027 to shorten prior authorization timelines, require clearer denial explanations, and move more requests online for certain Medicare Advantage, Medicaid, CHIP, and Marketplace plans. Here’s what’s changing — and what it means for patients.
End of content
End of content
